ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

DTIL Precision BioSciences Inc

12.74
-0.26 (-2.00%)
May 24 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Precision BioSciences Inc DTIL NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.26 -2.00% 12.74 19:00:00
Open Price Low Price High Price Close Price Previous Close
12.97 12.4016 13.207 12.74 13.00
more quote information »

Recent News

Date Time Source Heading
5/17/202406:00BWPrecision BioSciences Announces Grant of Inducement Awards..
5/13/202406:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
5/13/202406:15EDGAR2Form 8-K - Current report
5/13/202406:00BWPrecision BioSciences Reports First Quarter 2024 Financial..
5/08/202419:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
5/08/202419:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
5/08/202419:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
5/08/202419:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
5/08/202407:19EDGAR2Form 8-K - Current report
5/08/202407:15BWPrecision BioSciences Announces Common Stock Purchase by..
5/07/202415:30BWPrecision BioSciences to Report First Quarter Results on May..
5/07/202415:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
5/07/202415:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
5/07/202415:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
5/07/202415:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
5/07/202415:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
5/07/202415:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
5/07/202407:30BWPrecision BioSciences Announces Receipt of FDA Fast Track..
5/01/202406:05BWPrecision BioSciences Announces Late-Breaking Poster..
4/16/202415:15BWPrecision BioSciences Announces Return of Programs and..
3/27/202405:45BWPrecision BioSciences Reports Fourth Quarter and Fiscal Year..
3/20/202415:30BWPrecision BioSciences to Report Fourth Quarter and Fiscal..
3/19/202406:00BWPrecision BioSciences Presents Preclinical Data Highlighting..
3/06/202407:45BWPrecision BioSciences Announces MHRA Approval for Partner..
3/01/202407:00EDGAR2Form 8-K - Current report
3/01/202405:30BWPrecision BioSciences Announces $40.0 Million Offering of..
3/01/202405:00EDGAR2Form FWP - Filing under Securities Act Rules 163/433 of free..
2/29/202416:19EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2/29/202415:01BWPrecision BioSciences Announces Proposed Public Offering of..
2/20/202406:00BWPrecision BioSciences Announces Non-Exclusive Patent License..
2/14/202406:00BWPrecision BioSciences Receives Pre-IND Feedback from US FDA..
2/13/202407:29EDGAR2Form 8-K - Current report
2/13/202406:00BWPrecision BioSciences Promotes Naresh Tanna to Vice..
2/12/202410:00EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2/12/202406:00BWPrecision BioSciences Receives Initial $7.5 Million Cash..
2/09/202406:00BWPrecision BioSciences to Effect a Reverse Stock Split
1/23/202418:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/23/202418:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/23/202418:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/23/202418:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/23/202418:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/23/202416:29EDGAR2Form 8-K - Current report
1/23/202415:27EDGAR2Form 144 - Report of proposed sale of securities
1/22/202414:46EDGAR2Form 144 - Report of proposed sale of securities
1/22/202414:42EDGAR2Form 144 - Report of proposed sale of securities
1/22/202414:42EDGAR2Form 144 - Report of proposed sale of securities
1/19/202406:30EDGAR2Form 8-K - Current report
1/12/202407:00EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
1/11/202407:31EDGAR2Form 8-K - Current report
1/09/202408:20APSBiotech Massively Bid Up Before Opening Bell

Your Recent History

Delayed Upgrade Clock